Table 3.
Prognostic factors for disease-free survival | Univariate analysis | Multivariate analysis | Hazard Ratios | Confidence Interval |
---|---|---|---|---|
Age ≥65 years (n= 343, 48.7%) | 0.324 | NA | NA | NA |
Female gender (n= 259, 36.7%) | 0.956 | NA | NA | NA |
Synchronous presentation (n= 298, 42.3%) | 0.331 | NA | NA | NA |
IRT (n= 116, 21.4%)* | <0.001 | <0.001 | 1.551 | 1.217–1.975 |
Hemi-hepatectomy or more (n= 442, 62.7%) | 0.046 | 0.413 | 0.901 | 0.701–1.157 |
Blood transfusion (n= 149, 21.1%) | 0.007 | 0.002 | 1.473 | 1.155–1.877 |
High tumour burden (n= 289, 41%) | <0.001 | 0.023 | 1.205 | 1.026–1.416 |
R1 margin (n= 258, 36.6%) | <0.001 | 0.001 | 1.487 | 1.185–1.865 |
NA, not applicable; IRT, inflammatory response to tumour.
IRT was available in 543 (77.0%) patients.